There are several reports on the involvement of a single-nucleotide polymorphism (SNP: rs2279744, SNP309) of MDM2, which regulates the degradation of p53, with juvenile onset of soft tissue sarcoma and breast cancer as well as several other cancers [72]. This evidence concerns the gene TP53 and breast carcinoma.